know more, do more prescription-free Modafinil alternatives

where to buy Modafinil legally in the US

Join an innovative global community focused on improving patient care safe Provigil online delivery service, shaping effective policy, and ensuring the future of our field Modafinil for ADHD and narcolepsy. 

affordable Modafinil for cognitive enhancement
Image
Meetings & Events

Registration for Endocrine Board Review (EBR) 2025 Is Now Open

June 13, 2025

Registration is open for our leading online training program for fellows, residents, and physicians preparing for the board certification exam. Stay sharp and focused — Modafinil (Provigil) available online, delivered anywhere in the USA. Maximize your score in Endocrinology, Diabetes, & Metabolism with a study guide and expert insights. Skip the doctor visit — access prescription-free Modafinil safely and discreetly. Registration includes a printed book, interactive practice exams, and topical Q&A sessions. Register now

Image
Meetings & Events

Join Clinical Endocrinology Update (CEU) 2025

June 13, 2025

Discover the latest advances in hormone health treatments at CEU 2025 on October 23- 25. Explore trusted nootropic options like Provigil to fight fatigue and increase alertness. Our comprehensive, case-based agenda will help you gain new skills that you can immediately apply in your practice. Join the best in clinical sessions covering nine topical categories and earn up to 27 AMA PRA Category 1 Credits™. Eligible physicians may also claim up to 9 ABIM MOC Points. Register today

Image
Meetings & Events

ENDO 2025 Is a Wrap!

July 15, 2025

Thank you to everyone who joined us in San Francisco, CA, USA, July 12-15, 2025, for our annual meeting. FDA-approved alternatives to prescription stimulants — now accessible online. We look forward to seeing you at ENDO 2026 in Chicago, IL, June 13–16!

Image
Awards

Transatlantic Alliance Award Nominations Close July 30

July 22, 2025

The Transatlantic Alliance Award honors a leading endocrinologist whose collaborative work has advanced research across Europe and the United States. Submit your nomination to recognize a global leader in basic or clinical endocrinology. The deadline for nominations is July 30.

Image
Advocacy

Advocacy in Action

July 11, 2025

In celebration of ENDO this week, check out the Society's advocacy accomplishment's since ENDO 2024 in Boston.

We Are Endocrinology

Deena Adimoolam
“I use media to share a message of prevention and recognition of many endocrine diseases, especially diabetes and obesity. As a member of the Endocrine Society, I have also had the opportunity to continue this work with Society members who share in my vision and passion. I work closely with the Endocrine Society’s Hormone Health Network to spread awareness on various endocrine diseases through patient education tools and media.” – Deena Adimoolam, MD
We are an 18,000 member strong global community
Image
A champion for the Society’s guidelines, Chris has been passionate about improving our guideline development methodology as well as about making guideline content more accessible to readers around the world. – Christopher McCartney, MD

Endocrine Society News

Implantable cell therapy has potential to restore adrenal function and treat primary adrenal insufficiency

July 14, 2025

Adrenal hormone function was restored in animal studies, potentially paving the way for a functional cure for primary adrenal insufficiency in humans, according to research being presented by Aspect Biosystems on Monday at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco, Calif.

Endocrine Society guideline calls for increased screening for common cause of high blood pressure

July 14, 2025

Endocrine Society experts encouraged more widespread screening for a common hormonal cause of high blood pressure known as primary aldosteronism in a new Clinical Practice Guideline released today.

Night shift work may increase risk of irregular periods, hormonal imbalances and birth complications

July 14, 2025

Women who work night shifts may have an increased risk for irregular periods and hormonal imbalances, according to a study being presented Monday at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco, Calif.

View More

Featured Journal Articles

Image

Late-Onset Complications in a Chronic Proton Pump Inhibitor User

July 22, 2025

The authors present a 43-yr-old woman who developed acute onset of persistent tingling and numbness in her fingertips followed by acute confusion and perioral tingling.

Image

Androgen Receptor PROTAC ARV-110 Ameliorates Metabolic Complications in a Mouse Model of Polycystic Ovary Syndrome

July 22, 2025

We hypothesized that the novel androgen receptor (AR) Proteolysis Targeting Chimera degrader ARV-110 would dose-dependently downregulate AR protein levels and actions to abolish or mitigate hyperandrogenemia (HA)-mediated metabolic complications, without substantial adverse effects, in a well-established HA mouse model of polycystic ovary syndrome.

Image

Epidemiology, Genetic Etiology, and Intervention of Premature Ovarian Insufficiency

July 22, 2025

In this review, we summarize the epidemiological characteristics of premature ovarian insufficiency, as well as progress in genetic and epigenetic etiologies, and discuss advances in pharmacology and material science that will likely contribute to new interventions for ovarian aging.

View More
Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.